These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20652713)

  • 81. Development of a rapid and sensitive method for the quantitation of amphetamines in human plasma and oral fluid by LC-MS-MS.
    Wood M; De Boeck G; Samyn N; Morris M; Cooper DP; Maes RA; De Bruijn EA
    J Anal Toxicol; 2003 Mar; 27(2):78-87. PubMed ID: 12670001
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs.
    Wille SM; Raes E; Lillsunde P; Gunnar T; Laloup M; Samyn N; Christophersen AS; Moeller MR; Hammer KP; Verstraete AG
    Ther Drug Monit; 2009 Aug; 31(4):511-9. PubMed ID: 19571773
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Influence of ethanol on the pharmacokinetic properties of Δ9-tetrahydrocannabinol in oral fluid.
    Toennes SW; Schneider K; Wunder C; Kauert GF; Moeller MR; Theunissen EL; Ramaekers JG
    J Anal Toxicol; 2013 Apr; 37(3):152-8. PubMed ID: 23429905
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Investigating the correlation between wastewater analysis and roadside drug testing in South Australia.
    Bade R; Tscharke BJ; Longo M; Cooke R; White JM; Gerber C
    Drug Alcohol Depend; 2018 Jun; 187():123-126. PubMed ID: 29660696
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium.
    Montgomery D; Plate C; Alder SC; Jones M; Jones J; Christensen RD
    J Perinatol; 2006 Jan; 26(1):11-4. PubMed ID: 16281047
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Correspondence between Oral Fluid Drug Test Results and Self-Reported Illicit Drug Use among Music Festival Attendees.
    Gjerde H; Gjersing L; Furuhaugen H; Bretteville-Jensen AL
    Subst Use Misuse; 2019; 54(8):1337-1344. PubMed ID: 30860932
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Field Detection of Drugs of Abuse in Oral Fluid Using the Alere™ DDS®2 Mobile Test System with Confirmation by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS).
    Krotulski AJ; Mohr ALA; Friscia M; Logan BK
    J Anal Toxicol; 2018 Apr; 42(3):170-176. PubMed ID: 29301050
    [TBL] [Abstract][Full Text] [Related]  

  • 88. An evaluation of selected oral fluid point-of-collection drug-testing devices.
    Crouch DJ; Walsh JM; Flegel R; Cangianelli L; Baudys J; Atkins R
    J Anal Toxicol; 2005; 29(4):244-8. PubMed ID: 15975256
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Drugs and driving: the Finnish perspective.
    Lillsunde P; Gunnar T
    Bull Narc; 2005; 57(1-2):213-29. PubMed ID: 21338023
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Comparison of drug concentrations between whole blood and oral fluid.
    Langel K; Gjerde H; Favretto D; Lillsunde P; Øiestad EL; Ferrara SD; Verstraete AG
    Drug Test Anal; 2014 May; 6(5):461-71. PubMed ID: 24039237
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Sensitivity, specificity, and efficiency in detecting opiates in oral fluid with the Cozart Opiate Microplate EIA and GC-MS following controlled codeine administration.
    Barnes AJ; Kim I; Schepers R; Moolchan ET; Wilson L; Cooper G; Reid C; Hand C; Huestis MA
    J Anal Toxicol; 2003 Oct; 27(7):402-7. PubMed ID: 14606992
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Comparison of ELISAs for opiates, methamphetamine, cocaine metabolite, benzodiazepines, phencyclidine, and cannabinoids in whole blood and urine.
    Kerrigan S; Phillips WH
    Clin Chem; 2001 Mar; 47(3):540-7. PubMed ID: 11238309
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Results of the Queensland 2007-2012 roadside drug testing program: The prevalence of three illicit drugs.
    Davey J; Armstrong K; Martin P
    Accid Anal Prev; 2014 Apr; 65():11-7. PubMed ID: 24389088
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The Victorian legislative framework for the random testing drivers at the roadside for the presence of illicit drugs: an evaluation of the characteristics of drivers detected from 2004 to 2006.
    Boorman M; Owens K
    Traffic Inj Prev; 2009 Mar; 10(1):16-22. PubMed ID: 19214873
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Quantitation of cocaine and its major metabolites in human saliva using gas chromatography-positive chemical ionization-mass spectrometry (GC-PCI-MS).
    Cámpora P; Bermejo AM; Tabernero MJ; Fernández P
    J Anal Toxicol; 2003; 27(5):270-4. PubMed ID: 12908939
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Simultaneous Quantitative Determination of Amphetamines, Opiates, Ketamine, Cocaine and Metabolites in Human Hair: Application to Forensic Cases of Drug Abuse.
    Zhuo Y; Wang X; Wu J; Zhang S; Deng H; Liu W; Wu H; Xiang P; Shen M
    J Forensic Sci; 2020 Mar; 65(2):563-569. PubMed ID: 31498435
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Development and validation of a single LC-MS/MS assay following SPE for simultaneous hair analysis of amphetamines, opiates, cocaine and metabolites.
    Imbert L; Dulaurent S; Mercerolle M; Morichon J; Lachâtre G; Gaulier JM
    Forensic Sci Int; 2014 Jan; 234():132-8. PubMed ID: 24378313
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugs.
    Heltsley R; DePriest A; Black DL; Robert T; Marshall L; Meadors VM; Caplan YH; Cone EJ
    J Anal Toxicol; 2011 Oct; 35(8):529-40. PubMed ID: 22004671
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Cannabis findings in drivers suspected of driving under the influence of drugs in Finland from 2006 to 2008.
    Blencowe T; Pehrsson A; Mykkänen S; Gunnar T; Lillsunde P
    Forensic Sci Int; 2012 Apr; 217(1-3):107-12. PubMed ID: 22024655
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Drug testing in the workplace: could a positive test for one of the mandated drugs be for reasons other than illicit use of the drug?
    elSohly MA; Jones AB
    J Anal Toxicol; 1995 Oct; 19(6):450-8. PubMed ID: 8926740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.